DEVICE FOR DISPENSING A HYDROGEL INTO A VESSEL SYSTEM

DE602020064532T2Active Publication Date: 2025-12-24TEXAS HEART INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602020064532
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-09-05
Filing Date
2020-09-04
Publication Date
2025-12-24
Estimated Expiration
2040-09-04

AI Technical Summary

Technical Problem

Current treatments for ventricular arrhythmias, such as implantable cardiac defibrillators, are costly, painful, and ineffective in preventing re-entrant arrhythmias, and there is a need for a treatment that can restore electrical conduction across scarred myocardium without causing further cardiac damage.

Method used

A conductive hydrogel is delivered via a catheter into the myocardial vasculature, where it cures in situ to form a flexible, biostable, and conductive pathway across scarred myocardium, allowing for improved electrical conduction and reducing the need for defibrillation shocks.

Benefits of technology

The hydrogel restores electrical conduction across scarred myocardium, potentially eliminating re-entrant arrhythmias and reducing the power required for defibrillation, thereby preventing sudden cardiac death and improving cardiac rhythm management.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.